亿帆医药(002019.SZ):人生长激素注射液临床试验获批准

智通财经
23 Jun

智通财经APP讯,亿帆医药(002019.SZ)公告,公司全资子公司亿帆医药(上海)有限公司于近日收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,药品名称为:人生长激素注射液,国家药品监督管理局同意按生物类似药要求开展临床试验。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10